Senior Director, Facilities & Capital Projects | Equity Eligible

Antheia; Edison (CA); On-site; USD 235,000 - 280,000; Full time

Benefits offered by this job

Equity opportunities

Annual bonus potential

Job summary

Antheia is hiring a Senior Director of Facilities Operations and Capital Projects to lead Real Estate, Facilities & Maintenance, Security, EH&S, IT Administration, Lab Operations and Workplace across multiple sites.

The role requires 8+ years in facilities with 5+ years in management, strong budget and project management skills, and experience with regulatory agencies (DEA/FDA). Equity options and bonus potential are noted in compensation.

Qualifications

• Degree in engineering, architecture or related field; registrations/certifications preferred.
• Minimum 8 years in facilities with 5+ years in leadership roles.
• Experience with permitting and approvals, FDA/DEA familiarity.

Responsibilities

• Oversee day-to-day facility operations for multi-site biotech/manufacturing.
• Lead real estate, security, EH&S, IT administration and lab operations.
• Plan, budget and execute capital projects with on-schedule delivery.
• Manage vendor relationships and lease negotiations with owners/landlords.
• Ensure compliance with DEA, EPA, FDA and regulatory requirements.
• Provide site reporting and participate in audits/inspections.

Skills

Facilities management

Project management

Budgeting & cost control

Leadership & team management

Cross-functional collaboration

Regulatory compliance

Education

Bachelor's Degree in Engineering or Architecture

Professional registration/certifications

Tools

AutoCAD

Revit

Bluebeam

CMMS

Microsoft Office

Job description

Antheia is hiring a Senior Director of Facilities Operations and Capital Projects to lead Real Estate, Facilities & Maintenance, Security, EH&S, IT Administration, Lab Operations and Workplace across multiple sites.

The role requires 8+ years in facilities with 5+ years in management, strong budget and project management skills, and experience with regulatory agencies (DEA/FDA). Equity options and bonus potential are noted in compensation.